- Home
- RLYB vs NYC Comparison
RLYB vs NYC Comparison
Compare RLYB & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLYB | NYC |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7M | 25.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLYB | NYC |
|---|---|---|
| Price | $0.62 | $10.64 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 159.3K | 5.8K |
| Earning Date | 03-12-2026 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $674,000.00 | ★ $51,688,000.00 |
| Revenue This Year | $17.61 | $8.40 |
| Revenue Next Year | N/A | $1.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.71 | N/A |
| 52 Week Low | $0.22 | $7.03 |
| 52 Week High | $0.95 | $16.30 |
Technical Indicators
Market Signals| Indicator | RLYB | NYC |
|---|---|---|
| Relative Strength Index (RSI) | 38.26 | 73.82 |
| Support Level | $0.58 | $9.41 |
| Resistance Level | $0.74 | $9.30 |
| Average True Range (ATR) | 0.05 | 0.57 |
| MACD | -0.01 | 0.23 |
| Stochastic Oscillator | 27.46 | 95.66 |
Price Performance
Historical ComparisonAbout RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.